Evidence map›Paper›PMID 34535647›Full record

ArticleNature communications2021

Two-dimensional molybdenum carbide 2D-Mo

Hui Zhou, Zixuan Chen, Evgenia Kountoupi, Athanasia Tsoukalou, Paula M Abdala, Pierre Florian, Alexey Fedorov, Christoph R Müller

Abstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Harnessing Selectivity in COACS environmental Au · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. MoNanoscale advances · 2026
    Article
  7. Formation of Quasi-2D [MoJournal of the American Chemical Society · 2026
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Amorphous MoTeMaterials (Basel, Switzerland) · 2025
    Article
  16. S-decorated MoRSC advances · 2025
    Article
  17. Article
  18. Effect of the TiThe journal of physical chemistry. C, Nanomaterials and interfaces · 2025
    Article
  19. Article
  20. Recent Advances in Non-Ti MXenes: Synthesis, Properties, and Novel Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hui ZhouDepartment of Mechanical and Process Engineering, ETH Zürich, CH 8092, Zürich, Switzerland.ORCID http://orcid.org/0000-0003-1410-4794
Zixuan ChenDepartment of Mechanical and Process Engineering, ETH Zürich, CH 8092, Zürich, Switzerland.
Evgenia KountoupiDepartment of Mechanical and Process Engineering, ETH Zürich, CH 8092, Zürich, Switzerland.
Athanasia TsoukalouDepartment of Mechanical and Process Engineering, ETH Zürich, CH 8092, Zürich, Switzerland.ORCID http://orcid.org/0000-0002-2672-4969
Paula M AbdalaDepartment of Mechanical and Process Engineering, ETH Zürich, CH 8092, Zürich, Switzerland.ORCID http://orcid.org/0000-0002-2011-1707
Pierre FlorianCNRS, CEMHTI UPR3079, Université d'Orléans, F-45071, Orléans, France.ORCID http://orcid.org/0000-0003-4306-0815
Alexey FedorovDepartment of Mechanical and Process Engineering, ETH Zürich, CH 8092, Zürich, Switzerland. fedoroal@ethz.ch.ORCID http://orcid.org/0000-0001-9814-6726
Christoph R MüllerDepartment of Mechanical and Process Engineering, ETH Zürich, CH 8092, Zürich, Switzerland. muelchri@ethz.ch.ORCID http://orcid.org/0000-0003-2234-6902

Funding

EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 800419
6 · The paper itself

Abstract

Early transitional metal carbides are promising catalysts for hydrogenation of CO

Identifiers

PMID34535647
PMCPMC8448824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.